Red Teaming a Patient-Facing Clinical AI Platform: 2-Phase Prospective Study
JMIR AI · 16.11.2026 · 5 · e101912
DOI: 10.2196/101912 ↗Kurz gefasst
Fachartikel in der Zeitschrift JMIR AI, online erschienen am 16.11.2026. Verfasst von Javeed Sukhera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hartford Hospital, Hartford, CT, United States. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Health systems are increasingly deploying patient-facing conversational AI platforms, yet validated methodologies for safety evaluation under realistic high-risk conditions are lacking. Prior work has documented safety failures in clinical AI but not shown whether iterative, health system–embedded testing can produce measurable safety improvement.
Objective
This study aimed to evaluate a structured red teaming methodology for the safety assessment of a patient-facing clinical AI platform and determine whether targeted remediation guided by initial testing reduced safety failures in subsequent rounds of high-risk evaluations.
Methods
A 2-phase prospective simulation study was conducted at a single academic health system in January and February 2026. Phase 1 enrolled 48 health care professionals who completed 6 randomized clinical scenarios (3 medium risk and 3 high risk). Following independent platform remediation informed by aggregated phase 1 findings, phase 2 enrolled 27 additional participants who completed 8 targeted high-risk scenarios. All 476 transcripts were independently scored by 3 calibrated raters using a 5-domain safety rubric. A strict firewall separated the research team from the platform developer, and only aggregated, deidentified findings were shared between phases.
Results
In phase 1, the high-risk failure rate was 30.2% (35/116) of transcripts vs 5.6% (7/126) for medium-risk scenarios. In phase 2, the high-risk failure rate was 8.5% (20/234), representing an absolute difference of 21.7 percentage points (participant-clustered 95% CI 11.1-32.2) and a 72% relative difference, with comparable performance across prespecified and improvised prompts within the targeted failure categories. Interrater reliability was moderate to strong in phase 1 (intraclass correlation coefficient=0.66, 95% CI 0.62-0.69) and moderate in phase 2 (intraclass correlation coefficient=0.49, 95% CI 0.43-0.55). Agreement on the binary failure classification remained stable between phases (Fleiss κ=0.70 in both phases), with observed agreement increasing from 90.9% (220/242) to 94.9% (222/234). Residual failures clustered around triage calibration errors and scope violations.
Conclusions
Structured iterative red teaming was associated with improved safety performance on new high-risk scenarios following targeted remediation. The 5-domain rubric and scenario taxonomy offer a replicable methodology for health systems conducting predeployment and ongoing clinical AI safety assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hartford Hospital, Hartford, CT, United States.
ORCID-Profile: Javeed Sukhera, Emily Shearier, Sitra Nuredin Ababulgu, Gayathry Sunil, Peter Yoo, Manu Sharma
Zitieren
APA
Sukhera, J., Shearier, E., Ababulgu, S. N., Sunil, G., Yoo, P., & Sharma, M. (2026). Red Teaming a Patient-Facing Clinical AI Platform: 2-Phase Prospective Study. JMIR AI, 5, e101912. https://doi.org/10.2196/101912
Vancouver
Sukhera J, Shearier E, Ababulgu SN, Sunil G, Yoo P, Sharma M. Red Teaming a Patient-Facing Clinical AI Platform: 2-Phase Prospective Study. JMIR AI. 2026;5:e101912. doi:10.2196/101912
BibTeX
@article{Sukhera2026,
author = {Sukhera, Javeed and Shearier, Emily and Ababulgu, Sitra Nuredin and Sunil, Gayathry and Yoo, Peter and Sharma, Manu},
title = {Red Teaming a Patient-Facing Clinical AI Platform: 2-Phase Prospective Study},
journal = {JMIR AI},
year = {2026},
volume = {5},
pages = {e101912},
doi = {10.2196/101912}
}
EUVIMED